Company / Operating Income per Share
Immuneering Corp Operating Income per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.96
FY2023
5-year range
-$3.45 / -$1.96
FY2021-FY2023
Trend
+21.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-3.45 to $-1.96 over the past 2 years.
Based on SEC 10-K filings.
-1.96 in FY2023.
Improved from $-3.45 to $-1.96 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating income per share increased 21.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$1.96 | +21.2% |
| FY2022 | -$2.49 | +27.9% |
| FY2021 | -$3.45 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026